Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome.

Fitzgibbons SC, Jones BA, Hull MA, Zurakowski D, Duro D, Duggan C, Boctor D, Sigalet DL, Jaksic T.

J Pediatr Surg. 2010 Jan;45(1):95-9; discussion 99. doi: 10.1016/j.jpedsurg.2009.10.020.

2.

Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.

Cowles RA, Ventura KA, Martinez M, Lobritto SJ, Harren PA, Brodlie S, Carroll J, Jan DM.

J Pediatr Surg. 2010 Jan;45(1):84-7; discussion 87-8. doi: 10.1016/j.jpedsurg.2009.10.014.

PMID:
20105585
3.

Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion.

Mercer DF, Hobson BD, Fischer RT, Talmon GA, Perry DA, Gerhardt BK, Grant WJ, Botha JF, Langnas AN, Quiros-Tejeira RE.

J Pediatr Gastroenterol Nutr. 2013 Apr;56(4):364-9. doi: 10.1097/MPG.0b013e31827e208c.

PMID:
23201707
4.

Functional liver recovery parallels autologous gut salvage in short bowel syndrome.

Iyer KR, Horslen S, Torres C, Vanderhoof JA, Langnas AN.

J Pediatr Surg. 2004 Mar;39(3):340-4; discussion 340-4.

PMID:
15017549
5.

Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease.

Sigalet D, Boctor D, Robertson M, Lam V, Brindle M, Sarkhosh K, Driedger L, Sajedi M.

Eur J Pediatr Surg. 2009 Dec;19(6):348-53. doi: 10.1055/s-0029-1241865. Epub 2009 Oct 28.

PMID:
19866409
6.

Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.

Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M.

Pediatrics. 2008 Mar;121(3):e678-86. doi: 10.1542/peds.2007-2248.

PMID:
18310188
7.

Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.

Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS.

Nutr Clin Pract. 2010 Apr;25(2):199-204. doi: 10.1177/0884533610361477. Erratum in: Nutr Clin Pract. 2010 Jun;25(3):315.

PMID:
20413701
8.

Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure.

Hukkinen M, Kivisaari R, Lohi J, Heikkilä P, Mutanen A, Merras-Salmio L, Pakarinen MP.

Liver Int. 2016 Mar;36(3):361-9. doi: 10.1111/liv.12887. Epub 2015 Jun 25.

PMID:
26058319
9.

Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.

Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM.

Ann Surg. 2009 Sep;250(3):395-402. doi: 10.1097/SLA.0b013e3181b36657.

10.

Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.

Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M.

Pediatrics. 2006 Jul;118(1):e197-201.

PMID:
16818533
11.

Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children.

Le HD, de Meijer VE, Robinson EM, Zurakowski D, Potemkin AK, Arsenault DA, Fallon EM, Malkan A, Bistrian BR, Gura KM, Puder M.

Am J Clin Nutr. 2011 Sep;94(3):749-58. doi: 10.3945/ajcn.110.008557. Epub 2011 Jul 20.

12.

Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure.

Cavicchi M, Beau P, Crenn P, Degott C, Messing B.

Ann Intern Med. 2000 Apr 4;132(7):525-32.

PMID:
10744588
13.

Preventing parenteral nutrition liver disease.

Kelly DA.

Early Hum Dev. 2010 Nov;86(11):683-7. doi: 10.1016/j.earlhumdev.2010.08.012.

PMID:
20923719
14.

Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.

Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE.

JPEN J Parenter Enteral Nutr. 2012 Sep;36(5):587-95. doi: 10.1177/0148607111430507. Epub 2012 Jan 24.

PMID:
22275330
15.

Assessment and outcome of children with intestinal failure referred for intestinal transplantation.

Ganousse-Mazeron S, Lacaille F, Colomb-Jung V, Talbotec C, Ruemmele F, Sauvat F, Chardot C, Canioni D, Jan D, Revillon Y, Goulet O.

Clin Nutr. 2015 Jun;34(3):428-35. doi: 10.1016/j.clnu.2014.04.015. Epub 2014 Apr 30.

PMID:
25015836
16.

The use of Omegaven in treating parenteral nutrition-associated liver disease.

Park KT, Nespor C, Kerner J Jr.

J Perinatol. 2011 Apr;31 Suppl 1:S57-60. doi: 10.1038/jp.2010.182.

PMID:
21448206
17.

Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants.

Jakobsen MS, Jørgensen MH, Husby S, Andersen L, Jeppesen PB.

Dig Dis Sci. 2015 Jan;60(1):252-9. doi: 10.1007/s10620-014-3317-x. Epub 2014 Aug 9.

PMID:
25107446
18.

Necrotizing enterocolitis is associated with earlier achievement of enteral autonomy in children with short bowel syndrome.

Sparks EA, Khan FA, Fisher JG, Fullerton BS, Hall A, Raphael BP, Duggan C, Modi BP, Jaksic T.

J Pediatr Surg. 2016 Jan;51(1):92-5. doi: 10.1016/j.jpedsurg.2015.10.023. Epub 2015 Oct 23.

19.

Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure.

Mutanen A, Lohi J, Heikkilä P, Koivusalo AI, Rintala RJ, Pakarinen MP.

Hepatology. 2013 Aug;58(2):729-38. doi: 10.1002/hep.26360. Epub 2013 Jun 17.

PMID:
23460496
20.

Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.

Fallon EM, Le HD, Puder M.

Curr Opin Organ Transplant. 2010 Jun;15(3):334-40. Review.

PMID:
20503524

Supplemental Content

Support Center